Key result
Contrast media properties (iso-osmolar vs low-osmolar, ionic status) show uncertain differences in kidney injury and have not translated to differences in clinical cardiovascular outcomes.
Why the study?
Does the choice of contrast media (iso-osmolar vs low-osmolar, ionic vs non-ionic) impact renal and cardiovascular clinical outcomes?
Does the choice of contrast media (iso-osmolar vs low-osmolar, ionic vs non-ionic) impact renal and cardiovascular clinical outcomes?
Answers are grounded in this paper and cite their sources.
Differences between iso-osmolar and low-osmolar contrast media regarding kidney injury remain uncertain, and theoretical antithrombotic properties of ionic agents have not translated into improved clinical outcomes.
Contrast media vary in their ionic status, viscosity, osmolarity--and these factors all play into clinical effects. Iso-osmolar and low-osmolar contrast media dominate clinical use today. The differences between these two agents in terms of kidney injury remain uncertain. Ionic agents have theoretical properties which may help prevent thrombus formation; however this phenomenon has not translated to differences in clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Prasad et al. (2016) conducted a review in Patients receiving contrast media. Iso-osmolar and ionic contrast media vs. Low-osmolar and non-ionic contrast media was evaluated on Renal (kidney injury) and cardiovascular (thrombus formation) outcomes. Contrast media properties (iso-osmolar vs low-osmolar, ionic status) show uncertain differences in kidney injury and have not translated to differences in clinical cardiovascular outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: